Diabetic retinopathy: A clinical overview
1988; Wiley; Volume: 4; Issue: 4 Linguagem: Inglês
10.1002/dmr.5610040402
ISSN1099-0895
Autores Tópico(s)Retinopathy of Prematurity Studies
ResumoDiabetes/Metabolism ReviewsVolume 4, Issue 4 p. 291-322 Diabetic Complication Diabetic retinopathy: A clinical overview Matthew D. Davis, Matthew D. Davis Department of Ophthalmology, University of Wisconsin-Madison, Madison, Wisconsin 53792Search for more papers by this author Matthew D. Davis, Matthew D. Davis Department of Ophthalmology, University of Wisconsin-Madison, Madison, Wisconsin 53792Search for more papers by this author First published: June 1988 https://doi.org/10.1002/dmr.5610040402Citations: 16AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Larsen HW: Diabetic retinopathy. An ophthalmoscopic study with a discussion of the morphologic changes and the pathogenetic factors in this disease. Acta Ophthalmol (Copenhagen) 60: 1–89, 1960. 2 Beetham WP: Visual prognosis of proliferating diabetic retinopathy. Br J Ophthalmol 47: 611–619, 1963. 3 Dobree JH: Proliferative diabetic retinopathy: Evolution of the retinal lesions. Br J Ophthalmol 48: 637–649, 1964. 4 Davis D: Vitreous contraction in proliferative diabetic retinopathy. Arch Ophthalmol 74: 741–751, 1965. 5 Tolentino FI, Lee PF, Schepens CL: Biomicroscopic study of vitreous cavity in diabetic retinopathy. Arch Ophthalmol 75: 238–246, 1966. 6 Davis MD: The natural course of diabetic retinopathy, in Vascular Complications of Diabetes Mellitus. SJ Kimura and WM Caygil, Eds. Mosby, St. Louis, 1967, pp 139–169. 7 Davis MD, Myers FL, Engerman RL, et al.: Clinical observations concerning the pathogenesis of diabetic retinopathy, in Symposium on the Treatment of Diabetic Retinopathy. MF Goldberg and SL Fines, Eds. U.S. Government Printing Office (Public Health Service pub. no. 1890), Washington, D.C., 1969, pp 569–592. 8 Michaelson IC: The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK 68: 137–180, 1948. 9 Wise GN: Retinal neovascularization. Trans Am Ophthalmol Soc 54: 729–826, 1956. 10 Patz A: Clinical and experimental studies on retinal neovascularization. Am J Ophthalmol 94: 715–743, 1982. 11 Shimizu K, Kobayashi Y, and Murako K: Midperipheral fundus involvement in diabetic retinopathies. Ophthalmology 88: 601–612, 1981. 12 Glaser BM, D'Amore PA, Michels RG, Patz A, and Fenselau A: Demonstration of vasoproliferative activity from mammalian retina. J Cell Biol 84: 298–304, 1980. 13 Schreiber AB, Kenney J, Kowalski J, et al.: A unique family of endothelial cell polypeptide mitogens: The antigenic and receptor cross-reactivity of bovine endothelial cell growth factor, brain-derived acidic fibroblast growth factor, and eye-derived growth factor II. J. Cell Biol 101: 1623–1626, 1985. 14 Kuwabara T and Cogan DG: Retinal vascular patterns. I. Normal architecture. Arch Ophthalmol 64: 904–911, 1960. 15 Cogan DG, Toussaint D, and Kuwabara T: Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol 66: 366, 1961. 16 Kuwabara T and Cogan DG: Retinal vascular patterns. VI. Mural cells of the retinal capillaries. Arch Ophthalmol 69: 492–502, 1963. 17 Speiser P, Gittelsohn AM, and Patz A: Studies on diabetic retinopathy. III. Influence of diabetes on intramural pericytes. Arch Ophthalmol 80: 332–337, 1968. 18 Addison DJ, Garner A, and Ashton N: Degeneration of intramural pericytes in diabetic retinopathy. Br Med J 1: 264–266, 1970. 19 Engerman RL, Davis MD, and Bloodworth JMB: Retinopathy in experimental diabetes: Its relevance to diabetic retinopathy in man, in Diabetes. R Rodriguez and J Vallance-Owen, Eds. Excerpta Medica, Amsterdam, 1971, pp 261–267. 20 Ashton N: Pathogenesis of diabetic retinopathy, in Diabetic Retinopathy. HL Little, RL Jack, A Patz, PH Forsham, Eds. Theime-Stratton, New York, 1983, pp 85–106. 21 The Diabetes Control and Complications Trial Research Group: Color photography versus fluorescein angiography in the detection of diabetic retinopathy in the diabetes control and complication trial. Arch Ophthalmol 105: 1344–1351, 1987. 22 Bloodworth JMB: Fine structure of retina in human and canine diabetes mellitus, in Vascular Complications of Diabetes Mellitus. SJ Kimuara and WM Caygill, Eds. CV Mosby, St. Louis, 1967, pp 73–86. 23 Frank RN: On the pathogenesis of diabetic retinopathy. Ophthalmology 91: 626–634, 1984. 24 de Venecia G, Davis M, and Engerman R: Clinicopathologic correlations in diabetic retinopathy. I. Histology and fluorescein angiography of microaneurysms. Arch Ophthalmol 94: 1766–1773, 1976. 25 Early Treatment Diabetic Retinopathy Study Research Group: Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Arch Ophthalmol 103: 1796–1806, 1985. 26 Davis MD, Norton EWD, and Myers FL: Airlie classification of diabetic retinopathy, in Symposium on the Treatment of Diabetic Retinopathy. M Goldberg and SL Fine, Eds. U.S. Government Printing Office, Washington, D.C., 1969, pp 7–22. 27 Kohner EM: Pathogenic mechanisms in the development of diabetic retinopathy, in Diabetic Complications: Early Diagnosis and Treatment. D Andreani, G Crepaldi, U Di Mario, and G Pozza, Eds. John Wiley & Sons Ltd., 1987, pp 55–63. 28 Kinoshita JH: Aldose reductase in the diabetic eye. Am J Ophthalmol 102: 685–692, 1986. 29 Kennedy A, Frank RN, and Varma SD: Aldose reductase activity in retinal and cerebral microvessels and cultured vascular cells. Invest Ophthalmol Vis Sci 24: 1250–1258, 1983. 30 Atherton A, Hill DW, Keen H, Young S, and Edwards EJ: The effect of acute hyperglycaemia on the retinal circulation of the normal cat. Diabetologia 18: 233–237, 1980. 31 Ernest JT, Goldstick TK, and Engerman RL: Hyperglycemia impairs retinal oxygen autoregulation in normal and diabetic dogs. Invest Ophthalmol Vis Sci 24: 985–989, 1983. 32 Grunwald JE, Riva CE, Martin DB, Quint AR, Epstein PA: Effect of an insulin-induced decrease in blood glucose on the human diabetic retinal circulation. Ophthalmology 94: 1614–1620, 1987. 33 Kohner EM, Sleightholm M, and Fallon T: Why does retinopathy deteriorate when diabetic control is improved? Invest Ophthalmol Vis Sci 29 (suppl): 244, 1987. 34 Akagi Y, Kador PF, Kuwabara T, and Kinoshita JH: Aldose reductase localization in human retinal mural cells. Invest Ophthalmol Vis Sci 24: 1516–1519, 1983. 35 Engerman RL and Kern TS: Experimental galactosemia produces diabetic-like retinopathy. Diabetes 33: 97–100, 1984. 36 Frank RN, Keirn RJ, Kennedy A, and Frank KW: Galactose-induced retinal capillary basement membrane thickening: Prevention by sorbinil. Invest Ophthalmol Vis Sci 24: 1519–1524, 1983. 37 Robison WG, Kador PF, Akagi Y, et al.: Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, tolrestat. Diabetes 35: 195–199, 1986. 38 Chandler ML, Shannon WA, and DeSantis L: Prevention of retinal capillary basement membrane thickening in diabetic rats by aldose reductase inhibitors. Invest Ophthalmol Vis Sci 25: 159, 1984. 39 Taylor E and Dobree JH: Proliferative diabetic retinopathy: Site and size of initial lesions. Br ] Ophthalmol 54: 11–18, 1970. 40 Deckert T, Simonsen SE, and Poulsen JE: Prognosis of proliferative retinopathy in juvenile diabetes. Diabetes 16: 728–733, 1967. 41 The Diabetic Retinopathy Study Research Group: Photocoagulation treatment of proliferative diabetic retinopathy. The second report of diabetic retinopathy study findings. Ophthalmology 85: 82–106, 1978. 42 British Multicenter Study Group: Photocoagulation for proliferative diabetic retinopathy: A randomized controlled clinical trial using the xenon arch. Diabetologia 26: 109–115, 1984. 43 Rand LI, Prud'homme GJ, Ederer F, Canner PL, and The Diabetic Retinopathy Study Research Group: Factors influencing the development of visual loss in advanced diabetic retinopathy Invest Ophthalmol Vis Sci 26: 893–991, 1985. 44 The Diabetic Retinopathy Study Research Group: A modification of the Airlie House classification of diabetic retinopathy. Diabetic retinopathy study report no. 7. Invest Ophthalmol Vis Sci 21: 210–226, 1981. 45 Schwartz JS and Pavan PR: Optic disc edema. Int Ophthalmol Clin 24: 83–91, 1984. 46 Bresnick GH, Haight B, and de Venecia G: Retinal wrinkling and macular heterotopia in diabetic retinopathy. Arch Ophthalmol 97: 1890–1895, 1979. 47 Tasman W: Diabetic vitreous hemorrhage and its relationship to hypoglycemia. Mod Probl Ophthalmol 20: 413–414, 1979. 48 Anderson B: Activity and diabetic vitreous hemorrhages. Ophthalmology 87: 173–175, 1980. 49 Okun E and Cibis PA: The role of photocoagulation in the therapy of proliferative diabetic retinopathy. Arch Ophthalmol 75: 337–352, 1966. 50 Lee PF, McMeel JW, Schepens CL, and Field RA: A new classification of diabetic retinopathy. Am J Ophthalmol 62: 207–219, 1966. 51 Oakley N, Hill DW, Joplin GF, Kohner EM, and Fraser TR: Diabetic retinopathy I. The assessment of severity and progression by comparison with a set of standard fundus photographs. Diabetologia 3: 402–405, 1966. 52 Klein BEK, Davis MD, Segal P, et al.: Diabetic retinopathy. Assessment of severity and progression. Ophthalmology 91: 10–17, 1984. 53 Davis MD, Hubbard LD, Trautman J, and Klein R: Studies of retinopathy. Methodology for assessment and classification with fundus photographs. Diabetes 34 (suppl 13): 42–49, 1985. 54 The Diabetic Retinopathy Study Research Group: Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of DRS findings. Diabetic retinopathy study report no. 8. Ophthalmology 88: 583–600, 1981. 55 Klein R, Davis MD, Moss SE, Klein BEK, and DeMets DL: The Wisconsin epidemiologic study of diabetic retinopathy: A comparison of retinopathy in younger and older onset diabetic person, in Comparison of Type I and Type II Diabetes. M Vranic, C Hollenberg, and G Steiner, Eds. Plenum Publishing Corp., New York, 1985, pp 321–325. 56 The Diabetic Retinopathy Vitrectomy Study Research Group: Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. Diabetic retinopathy vitrectomy study report 2. Arch Ophthalmol 103: 1644–1652, 1985. 57 The Diabetic Retinopathy Study Research Group: Design, methods, and baseline results. Diabetic retinopathy study report no. 6. Invest Ophthalmol Vis Sci 21: 149–209, 1981. 58 Aiello LM, Rand LI, Briones JC et al.: Diabetic retinopathy in Joslin Clinic patients with adult-onset diabetes. Ophthalmology 88: 619–623, 1981. 59 The Diabetes Control and Complications Trial Research Group: Design and methodologic considerations for the feasibility phase. Diabetes 35: 530–545, 1986. 60 Klein R, Klein BEK, Moss SE, Davis MD, and DeMets DL: The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102: 527–532, 1984. 61 Howard-Williams J, Hillson RM, Bron A, Awdry P, et al.: Retinopathy is associated with higher glycemia in maturity-onset type diabetes. Diabetologia 27: 198–202, 1984. 62 Hockaday TDR, Pandher KS, Bron A, et al.: Progression of established retinopathy is unrelated to glycosylated hemoglobin in non-insulin-dependent diabetes. Transplant Proc XVIII: 1574–1575, 1986. 63 Constam GR: Zur Spatprognose des Diabetes mellitus. Helv Med Acta 32: 287, 1965. 64 Caird FI: Diabetes and the Eye. Blackwell Scientific Publications, Oxford, 1968, p 84. 65 Knatterud GL, Klimt CR, Levin ME, Jacobson ME, and Goldner MG: Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment. JAMA 240: 37–42, 1978. 66 Kilo C, Miller JP, and Williamson JR: The crux of the UGDP. Diabetologia 18: 179–185, 1980. 67 Doft BH, Kingsley LA, Orchard IJ, Kuller L, Drash A, and Becker D: The association between long term diabetic control and early retinopathy. Ophthalmology 91: 763–768, 1984. 68 Bodansky HJ, Cudworth AG, Drury PL, and Kohner EM: Risk factors associated with severe proliferative retinopathy in insulin-dependent diabetes mellitus. Diabetes Care 5: 97–100, 1982. 69 Rand LI, Krolewski AS, Aiello LM, et al.: Multiple factors in the prediction of risk of proliferative diabetic retinopathy. N Engl J Med 313: 1433–1437, 1985. 70 Dornan T, Mann JI, and Turner R: Factors protective against retinopathy in insulin-dependent diabetics free of retinopathy for 30 years. Br Med J 285: 1073–1077, 1982, 71 Davis MD: Discussion of Doft, et al.61 Ophthalmology 91: 768–769, 1984. 72 Krolewski AS, Warram JH, Rand LI, Christlieb AR, Busick EJ, and Kahn CR: Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: A 40-yr follow-up study. Diabetes Care 9: 443–452, 1986. 73 Krolewski AS, Rand LI, Warram JH, and Aiello LM: Proliferative diabetic retinopathy (PDR) risk is closely related to hemoglobin Alc (AlC) level. Diabetes 34 (suppl 1): 71A, 1985. 74 Klein R, Klein BEK, Moss SE, and DeMets D: Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. Submitted for publication. 75 Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T, and The Steno Study Group: Effect of one year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet i: 200–204, 1983. 76 The Kroc Collaborative Study Group: Blood glucose control and the evolution of diabetic retinopathy and albuminuria. N Engl J Med 311: 365–372, 1984. 77 Lauritzen T, Frost-Larsen K, Larsen HW, et al.: Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 34: 74–79, 1985. 78 Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik KF, Aagenaes O, and the Aker Diabetes Group: Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin-dependent diabetes mellitus: The Oslo study. Br Med J 290: 811–815, 1985. 79 Beck-Nielsen H, Rickelsen B, Mogensen CE, et al.: Effect of insulin pump treatment for one year on renal function and retinal morphology in patients with IDDM. Diabetes Care 8: 585–589, 1985. 80 Brinchmann-Hansen O, Dahl-Jorgensen K, Hanssen KF, Sandvik L, and the Oslo Study Group: Effects of intensified treatment on various lesions of diabetic retinopathy. Am ] Ophthalmol 100: 644–653, 1985. 81 The Kroc Collaborative Study Group: The Kroc study patients at two years: A report on further retinal changes. Diabetes 34: 39, 1985. 82 Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik KF, Aagenaes O, and the Aker Diabetes Group: Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin-dependent diabetes mellitus: The Oslo study. Br Med J 293: 1195–1199, 1986. 83 Verrillo A, de Teresa A, Martino C, et al.: Long-term improvement of metabolic control does not affect progression of background retinopathy. Transplant Proc XVIII: 1569–1570, 1986. 84 Irsigler K, Kritz H, and Najemnik C: Reversal of florid diabetic retinopathy. Lancet ii: 1068, 1979. 85 White MC, Kohner EM, Pickup JC, and Keen H: Reversal of diabetic retinopathy by continuous subcutaneous insulin infusion: A case report. Br J Ophthalmol 65: 307–311, 1981. 86 Pucklin JE, Tamborlane WV, Felig P, et al.: Influence of long-term insulin infusion pump treatment of type I diabetes on diabetic retinopathy. Ophthalmology 89: 735–747, 1982. 87 Lawson PM, Champion MC, Canny C, et al.: Continuous subcutaneous insulin infusion does not prevent progression of proliferative and pre-proliferative retinopathy. Br J Ophthalmol 66: 762–766, 1982. 88 van Ballegooie E, Hooymans JM, Timmerman Z, et al.: Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion. Diabetes Care 7: 236–242, 1984. 89 Daneman D, Drash AL, Lobes LH, et al.: Progressive retinopathy with improved control in diabetic dwarfism (Mauriac's syndrome). Diabetes Care 4: 360–365, 1981. 90 Lawrence JR, Bedford GJ, and Thomson R: Rapid development during puberty of proliferative retinopathy after strict control. Lancet ii: 322, 1985. 91 Dandona P, Bolger JP, Boag F, Fonesca V, and Abrams JD: Rapid development and progression of proliferative retinopathy after strict diabetic control. Br Med J 290: 895–896, 1985. 92 Ramsay RC, Goetz FC, Sutherland DER, Mauer SM, et al.: Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med 318: 208–214, 1988. 93 Engerman RL, Bloodworth JMB, and Nelson S: Relationship of microvascular disease in diabetes to metabolic control. Diabetes 26: 760–769, 1977. 94 Engerman RL and Kern TS: Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 36: 808–812, 1987. 95 The DCCT Research Group: Diabetes control and complications trial (DCCT): Results of feasibility study. Diabetes Care 10: 1–19, 1987. 96 Meyer-Schwickerath G: Light coagulation (translated by SM Drance). Mosby, St. Louis, 1960. 97 Beetham WP, Aiello JM, Balodimos MC, and Koncz L: Ruby laser photocoagulation of early diabetic neovascular retinopathy. Trans Am Ophthalmol Soc 67: 39–67, 1969. 98 The Early Treatment Diabetic Retinopathy Study Research Group: Techniques for scatter and local photocoagulation treatment of diabetic retinopathy. Early treatment diabetic retinopathy study report no. 3. Int Ophthalmol Clin 27: 254–264, 1987. 99 Rubinstein K and Myska V: Pathogenesis and treatment of diabetic maculopathy. Br ] Ophthalmol 58: 76–84, 1974. 100 British Multicenter Study Group: Photocoagulation for diabetic maculopathy. Diabetes 32: 1010–1016, 1983. 101 Patz A, Schatz H, Berkow JW, et al.: Macular edema—An overlooked complication of diabetic retinopathy. Trans Am Acad Ophthalmol Otolaryngol 77: 34–42, 1973. 102 Early Treatment Diabetic Retinopathy Study Research Group: Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Arch Ophthalmol 103: 1796–1806, 1985. 103 Early Treatment Diabetic Retinopathy Study Research Group: Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early treatment diabetic retinopathy study report number 2. Ophthalmology 94: 761–774, 1987. 104 Olk RJ: Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 93: 938–950, 1986. 105 Little HL, Zweng C, Jack RL, and Vassiliadis A: Techniques of argon laser photocoagulation of diabetic disk new vessels. Am J Ophthalmol 82: 675–683, 1976. 106 Wolbarsht ML and Landers MB: The rationale of photocoagulation therapy for proliferative diabetic retinopathy: A review and a model. Ophthalmic Surg 11: 235–245, 1980. 107 Weiter JJ and Zuckerman R: The influence of the photoreceptor-RPE complex on the inner retina; an explanation for the beneficial effects of photocoagulation. Ophthalmology 87: 1133–1139, 1980. 108 Molnar J, Poitry S, Tsacopoulos M, et al.: Effect of laser photocoagulation on oxygenation of the retina in miniature pigs. Invest Ophthalmol Vis Sci 26: 1410–1414, 1985. 109 Grunwald JE, Riva CE, Bruckner AJ, et al.: Altered vascular response to 100% oxygen breathing in diabetes mellitus. Ophthalmology 91: 1447–1452, 1984. 110 Glaser BM, Campochiaro PA, Davis DL Jr., and Sato M: Retinal pigment epithelial cells release an inhibitor of neovascularization. Arch Ophthalmol 103: 1870–1875, 1985. 111 Peyman GA and Bok D: Peroxidase diffusion in the normal and laser-photocoagulated primate retina. Invest Ophthalmol 11: 35–45, 1972. 112 Marshall J, Clover G, and Rothery S: Some new findings on retinal irradiation by krypton and argon lasers. Doc Ophthalmol 36: 21–37, 1984. 113 Bresnick GH: Diabetic macular edema. Ophthalmology 93: 989–997, 1986. 114 The Diabetic Retinopathy Study Research Group: Preliminary report on the effects of photocoagulation therapy. Am J Ophthalmol 81: 383–396, 1976. 115 Meyer-Schwickerath G, and Gerke E: Bjerrum lecture. Treatment of diabetic retinopathy with photocoagulation. Results of photocoagulation therapy of proliferative retinopathy in childhood-onset and maturity-onset diabetes and an approach to the dosage of photocoagulation. Acta Ophthalmol (Copenhagen) 61: 756–768, 1983. 116 Okun E, Johnston GP, Boniuk I, Arribas NP, Escoffrey RF, and Grand MG: Xenon arc photocoagulation of proliferative diabetic retinopathy. Ophthalmology 91: 1458–1463, 1984. 117 Murphy RP and Ferris FL: The current status of the early treatment diabetic retinopathy study. Ophthalmic Forum 2: 149–152, 1984. 118 The Early Treatment Diabetic Retinopathy Research Group: Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report no. 4. Int Ophthalmol Clin 27: 265–272, 1987. 119 Machemer R, Buettner H, Norton EWD, and Parel JM: Vitrectomy: A pars plana approach. Ophthalmology 75: 813, 1971. 120 Michels RG and de Bustros S: Vitreous surgery for visual loss from proliferative diabetic retinopathy, in the Retinal-Renal Syndrome. EA Friedman and FA L'Esperance, Eds. Grune & Stratton, New York, 1986, pp 265–282. 121 Rice TA, Michels RC, Maguire MG, and Rice EF: The effect of lensectomy on the incidence of iris neovascularization and neovascular glaucoma after vitrectomy for diabetic retinopathy. Am J Ophthalmol 95: 1–11, 1963. 122 de Bustros S, Thompson JT, Michels RG, and Rice TA: Vitrectomy for progressive proliferative diabetic retinopathy. Arch Ophthalmol 105: 196–199, 1987. 123 O'Hanley GP and Canny CLB: Diabetic dense premacular hemorrhage. A possible indication for prompt vitrectomy. Ophthalmology 92: 507–511, 1985. 124 Ramsay RC, Knobloch WH, and Cantrill HL: Timing of vitrectomy for active proliferative diabetic retinopathy. Ophthalmology 93: 283–289, 1986. 125 Kupfer C: A new patient group in the diabetic retinopathy vitrectomy study. Arch Ophthalmol 99: 65, 1981. Citing Literature Volume4, Issue4June 1988Pages 291-322 ReferencesRelatedInformation
Referência(s)